JP2022512399A5 - - Google Patents
Info
- Publication number
- JP2022512399A5 JP2022512399A5 JP2021533537A JP2021533537A JP2022512399A5 JP 2022512399 A5 JP2022512399 A5 JP 2022512399A5 JP 2021533537 A JP2021533537 A JP 2021533537A JP 2021533537 A JP2021533537 A JP 2021533537A JP 2022512399 A5 JP2022512399 A5 JP 2022512399A5
- Authority
- JP
- Japan
- Prior art keywords
- peaks
- compound
- scale
- xrpd pattern
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023221085A JP7783870B2 (ja) | 2018-12-13 | 2023-12-27 | キナーゼ阻害剤の結晶性形態及び塩形態 |
| JP2025208367A JP2026031599A (ja) | 2018-12-13 | 2025-11-28 | キナーゼ阻害剤の結晶性形態及び塩形態 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862779430P | 2018-12-13 | 2018-12-13 | |
| US62/779,430 | 2018-12-13 | ||
| US201962856469P | 2019-06-03 | 2019-06-03 | |
| US62/856,469 | 2019-06-03 | ||
| PCT/US2019/065972 WO2020123800A1 (en) | 2018-12-13 | 2019-12-12 | Crystalline forms and salt forms of a kinase inhibitor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023221085A Division JP7783870B2 (ja) | 2018-12-13 | 2023-12-27 | キナーゼ阻害剤の結晶性形態及び塩形態 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022512399A JP2022512399A (ja) | 2022-02-03 |
| JP2022512399A5 true JP2022512399A5 (enExample) | 2022-12-19 |
| JP7509779B2 JP7509779B2 (ja) | 2024-07-02 |
Family
ID=69160358
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021533537A Active JP7509779B2 (ja) | 2018-12-13 | 2019-12-12 | キナーゼ阻害剤の結晶性形態及び塩形態 |
| JP2023221085A Active JP7783870B2 (ja) | 2018-12-13 | 2023-12-27 | キナーゼ阻害剤の結晶性形態及び塩形態 |
| JP2025208367A Pending JP2026031599A (ja) | 2018-12-13 | 2025-11-28 | キナーゼ阻害剤の結晶性形態及び塩形態 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023221085A Active JP7783870B2 (ja) | 2018-12-13 | 2023-12-27 | キナーゼ阻害剤の結晶性形態及び塩形態 |
| JP2025208367A Pending JP2026031599A (ja) | 2018-12-13 | 2025-11-28 | キナーゼ阻害剤の結晶性形態及び塩形態 |
Country Status (33)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117402114A (zh) * | 2018-01-26 | 2024-01-16 | 埃克塞里艾克西斯公司 | 用于治疗激酶依赖性病症的化合物 |
| MX2021014773A (es) * | 2019-06-03 | 2022-01-18 | Exelixis Inc | Formas de sales cristalinas de un inhibidor de cinasas. |
| CN115461328B (zh) * | 2020-04-30 | 2025-11-07 | 埃克塞里艾克西斯公司 | 用于制备激酶抑制剂的方法 |
| IL300151A (en) * | 2020-07-31 | 2023-03-01 | Exelixis Inc | Combinations for cancer treatment |
| JP2023548855A (ja) * | 2020-11-05 | 2023-11-21 | エグゼリクシス， インコーポレイテッド | キナーゼ阻害剤の医薬組成物 |
| CN112650176B (zh) * | 2020-12-22 | 2022-08-30 | 天能化工有限公司 | 一种盐酸解析开停车工序的dcs控制方法 |
| TW202334090A (zh) * | 2021-11-03 | 2023-09-01 | 美商艾克塞里克斯公司 | 用於治療激酶依賴性病症之化合物 |
| US20250368606A1 (en) | 2021-12-22 | 2025-12-04 | Exelixis, Inc. | Crystalline forms and salt forms of a kinase inhibitor |
| CN116751161A (zh) * | 2023-06-28 | 2023-09-15 | 中国人民解放军军事科学院军事医学研究院 | 喹啉类化合物及其制备方法、药物组合物及医药用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2210607B1 (en) * | 2003-09-26 | 2011-08-17 | Exelixis Inc. | N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide for the treatment of cancer |
| CA2604238C (en) | 2005-04-15 | 2015-07-07 | Neogenix Oncology, Inc. | Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| ES2599458T3 (es) | 2008-10-14 | 2017-02-01 | Sunshine Lake Pharma Co., Ltd. | Compuestos y métodos de uso |
| NZ779754A (en) | 2009-01-16 | 2023-04-28 | Exelixis Inc | Malate salt of n-(4-{ [6,7-bis(methyloxy)quinolin-4-yl] oxy} phenyl)-n’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer |
| CN102408411B (zh) | 2011-09-19 | 2014-10-22 | 北京康辰药业股份有限公司 | 一种含喹啉基的羟肟酸类化合物及其制备方法、以及含有该化合物的药物组合物及其应用 |
| BR112015007672A2 (pt) | 2012-10-04 | 2017-08-08 | Dana Farber Cancer Inst Inc | anticorpos anti-pd-l1 monoclonais humanos e métodos de uso |
| SMT202100065T1 (it) | 2013-05-02 | 2021-03-15 | Anaptysbio Inc | Anticorpi diretti contro la proteina della morte programmata (pd-1) |
| BR112016018450A2 (pt) | 2014-02-14 | 2018-09-18 | Exelixis Inc | formas sólidas cristalinas de n-{4-[(6,7-dimetoxiquinolin-4-il)oxi]fenil}-n'-(4-fluorofenil)ciclopropano-1,1-dicarboxamida, processos de preparo e métodos de uso |
| CN104817497B (zh) | 2015-03-20 | 2017-03-08 | 南京众睿缘生物科技有限公司 | 一种炔代喹啉衍生物及其制备方法和用途 |
| MA48776A (fr) | 2017-05-26 | 2020-04-08 | Exelixis Inc | Formes solides cristallines de sels de n-{4-[(6,7-diméthoxyquinolin-4-yl) oxy]phényl}-n'-(4-fluorphényl) cyclopropane-1,1-dicarboxamide, procédés de préparation et d'utilisation |
| CN117402114A (zh) * | 2018-01-26 | 2024-01-16 | 埃克塞里艾克西斯公司 | 用于治疗激酶依赖性病症的化合物 |
| MX2021014773A (es) * | 2019-06-03 | 2022-01-18 | Exelixis Inc | Formas de sales cristalinas de un inhibidor de cinasas. |
-
2019
- 2019-12-12 KR KR1020217021734A patent/KR102828472B1/ko active Active
- 2019-12-12 PL PL19836338.4T patent/PL3894012T3/pl unknown
- 2019-12-12 JP JP2021533537A patent/JP7509779B2/ja active Active
- 2019-12-12 PT PT198363384T patent/PT3894012T/pt unknown
- 2019-12-12 IL IL320433A patent/IL320433A/en unknown
- 2019-12-12 GE GEAP201915695A patent/GEP20247596B/en unknown
- 2019-12-12 DK DK19836338.4T patent/DK3894012T3/da active
- 2019-12-12 ES ES19836338T patent/ES3052838T3/es active Active
- 2019-12-12 WO PCT/US2019/065972 patent/WO2020123800A1/en not_active Ceased
- 2019-12-12 HU HUE19836338A patent/HUE072868T2/hu unknown
- 2019-12-12 MA MA54458A patent/MA54458B1/fr unknown
- 2019-12-12 MD MDE20211022T patent/MD3894012T2/ro unknown
- 2019-12-12 LT LTEPPCT/US2019/065972T patent/LT3894012T/lt unknown
- 2019-12-12 PE PE2021000862A patent/PE20211757A1/es unknown
- 2019-12-12 FI FIEP19836338.4T patent/FI3894012T3/fi active
- 2019-12-12 CR CR20210375A patent/CR20210375A/es unknown
- 2019-12-12 KR KR1020257021669A patent/KR20250103803A/ko active Pending
- 2019-12-12 SI SI201930963T patent/SI3894012T1/sl unknown
- 2019-12-12 EP EP25183289.5A patent/EP4631505A3/en active Pending
- 2019-12-12 AU AU2019395419A patent/AU2019395419B2/en active Active
- 2019-12-12 CA CA3122840A patent/CA3122840A1/en active Pending
- 2019-12-12 RS RS20250909A patent/RS67216B1/sr unknown
- 2019-12-12 MX MX2021006951A patent/MX2021006951A/es unknown
- 2019-12-12 SG SG11202105949RA patent/SG11202105949RA/en unknown
- 2019-12-12 US US17/312,658 patent/US12017995B2/en active Active
- 2019-12-12 BR BR112021011333-9A patent/BR112021011333A2/pt unknown
- 2019-12-12 SM SM20250346T patent/SMT202500346T1/it unknown
- 2019-12-12 IL IL283860A patent/IL283860B2/en unknown
- 2019-12-12 HR HRP20251122TT patent/HRP20251122T1/hr unknown
- 2019-12-12 CN CN201980090041.5A patent/CN113329790A/zh active Pending
- 2019-12-12 EP EP19836338.4A patent/EP3894012B1/en active Active
- 2019-12-13 TW TW108145868A patent/TWI852963B/zh active
-
2021
- 2021-06-04 ZA ZA2021/03844A patent/ZA202103844B/en unknown
- 2021-06-09 PH PH12021551356A patent/PH12021551356A1/en unknown
- 2021-06-10 CO CONC2021/0007613A patent/CO2021007613A2/es unknown
- 2021-06-11 CL CL2021001537A patent/CL2021001537A1/es unknown
-
2023
- 2023-12-27 JP JP2023221085A patent/JP7783870B2/ja active Active
-
2024
- 2024-05-07 US US18/657,052 patent/US20240300897A1/en active Pending
-
2025
- 2025-09-22 AU AU2025234277A patent/AU2025234277A1/en active Pending
- 2025-11-28 JP JP2025208367A patent/JP2026031599A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022512399A5 (enExample) | ||
| JP7288904B2 (ja) | ビアリールエーテル型キナゾリン誘導体 | |
| DK2970303T5 (en) | SUBSTITUTED XANTHINES AND PROCEDURES FOR USING IT | |
| EP2597955B1 (en) | Quinoline derivatives and melk inhibitors containing the same | |
| JP6469567B2 (ja) | Ｅｇｆｒ発動性がんの細胞増殖阻害用化合物 | |
| CA2595834C (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | |
| EP1406877A1 (en) | Heterocyclic amines for the treatment of conditions associated with gsk-3 | |
| CA3029175C (en) | Novel pyrazole derivatives as alk5 inhibitors and uses thereof | |
| KR20180050405A (ko) | B형 간염 코어 단백질 조정제 | |
| JP2015514060A5 (enExample) | ||
| KR102142797B1 (ko) | 피리디닐아미노피리미딘 유도체의 메실레이트 염의 결정질 형태, 그의 제조 방법, 및 그의 용도 | |
| CN105263930A (zh) | 作为lrrk2抑制剂的芳基吡咯并吡啶衍生的化合物 | |
| JP2022535072A5 (enExample) | ||
| KR20210102942A (ko) | 치환된 아릴메틸우레아 및 헤테로아릴메틸우레아, 이의 유사체, 및 이의 사용 방법 | |
| JP2016505584A (ja) | ダウン症候群及びアルツハイマー病に関連する認知欠損の治療のための、ｄｙｒｋ１ａタンパク質阻害剤としての３，５−ジアリールアザインドール類 | |
| WO2025153625A1 (en) | Imidazo[1,2-d][1,2,4]triazine derivatives for use as inhibitors of the nlrp3 inflammasome pathway | |
| KR102114389B1 (ko) | 신규 소듐채널 저해 화합물, 이의 제조방법, 및 이를 포함하는 소듐채널 관련 질환의 예방 또는 치료용 약학적 조성물 | |
| JP2022500441A5 (enExample) | ||
| KR102054640B1 (ko) | 아데노신 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물 | |
| KR20190128671A (ko) | 중수소화 벤즈이미다졸 화합물 및 그의 의약 용도 | |
| CN109952296A (zh) | 4-氰基-n-(2-(4,4-二甲基环己-1-烯-1-基)-6-(2,2,6,6-四甲基四氢-2h-吡喃-4-基)吡啶-3-基)-1h-咪唑-2-甲酰胺的结晶形式 | |
| JP2005154434A (ja) | ２−アミノキナゾリン誘導体 | |
| TWI328581B (en) | New compounds | |
| HK1240215B (zh) | 取代的黄嘌呤及其使用方法 | |
| EA041321B1 (ru) | Кристаллические формы 4-циано-n-(2-(4,4-диметилциклогекс-1-ен-1-ил)-6-(2,2,6,6-тетраметилтетрагидро-2h-пиран-4-ил)пиридин-3-ил)-1h-имидазол-2-карбоксамида |